Guardant Health, Inc., a leading precision oncology company, launched Shield Across America: a historic coast-to-coast mobile screening tour bringing Shield, the first and only FDA-approved blood test as a primary colorectal cancer (CRC) screening option and recommended in national guidelines.
Guardant Health, Inc., a leading precision oncology company, launched Shield Across America: a historic coast-to-coast mobile screening tour bringing Shield, the first and only FDA-approved blood test as a primary colorectal cancer (CRC) screening option and recommended in national guidelines.
Guardant Health, Inc., a leading precision oncology company, launched Shield Across America: a historic coast-to-coast mobile screening tour bringing Shield, the first and only FDA-approved blood test as a primary colorectal cancer (CRC) screening option and recommended in national guidelines.
